Reimagining the future of healthcare
ASHLEY / Huntington’s Disease Community Advocate
Press Releases
Subscribe to receive breaking news alerts about uniQure.
Subscribe-
-
uniQure Announces Sale of Commercial Manufacturing Facility to Genezen
-
uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease